AOD-9604

hGH fragment 176-191

AOD-9604 is a modified fragment of the C-terminus of human growth hormone (176-191) — valued for targeted lipolysis support without IGF-1 axis interference and without effect on blood glucose or growth. Typical Course: A full course runs 12 weeks at a consistent dose (300mcg) once daily on an empty stomach, ideally around 30 minutes before food for optimal effect. Most customers notice initial effects around week 4, with results peaking around week 10. What to Expect: Stimulated lipolysis, supported fat metabolism, no IGF-1 interference and changes in energy levels. Key benefits include no effect on the IGF-1 axis, a fat-specific mechanism, once-daily dosing and a good safety profile. Considerations & Safety: Visible results take longer to appear (around 4 weeks), dosing must be on an empty stomach, and the effect is milder than full growth hormone or newer compounds. Common side effects include injection site redness, mild headache, fatigue and rare nausea. Seek medical attention immediately if you notice unusual swelling beyond the application site, severe allergic reaction, or chest tightness.